Elite Announces Drug Application Filing For Synthetic Narcotic Analgesic Accepted by FDA (GlobeNewswire via Yahoo! Finance)
NORTHVALE, N.J., Sept. 29, 2008 -- Elite Pharmaceuticals, Inc. in collaboration with ThePharmaNetwork, LLC., announced today the acceptance by the U.S. Food and Drug Administration of the Abbreviated New Drug Application for a generic equivalent of a synthetic narcotic analgesic drug product.

FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval (PR Newswire via Yahoo! Finance)
Eli Lilly and Company announced today it received approval from the U.S. Food and Drug Administration for the use of ALIMTA , in combination with cisplatin, in the first-line treatment of locally-advanced and metastatic non-small cell lung cancer , for patients with nonsquamous histology.

Cepheid Receives FDA Clearance For First Rapid On Demand Molecular Diagnostic Test For MRSA And S. Aureus (Medical News Today)
Cepheid (Nasdaq: CPHD) announced it has received clearance from the U.S.